Dr. Emilija Veljkovic
      OUR PEOPLE

      Dr. Emilija Veljkovic

      PhD in molecular biology and physiology

      Manager Scientific & Medical Affairs

      Contact

      Emilija joined PMI in 2007 and is currently Manager of Scientific & Medical Affairs. She is a molecular biologist with a PhD in molecular biology and physiology from the Medical Faculty of the University of Zurich in Switzerland.

      Previously, she led a team of scientists responsible for the design and data interpretation of in vivo product assessment studies in Singapore and is the lead author on many publications and book chapters. Emilija was a leading author of the book Nicotine and other tobacco compounds in neurodegenerative and psychiatric diseases published in 2018. The book provides a summary of the epidemiological data on smoking and several neurological disorders, describing the complex relationships between smoking and neurological disease and the bioactive compounds found in tobacco.

      Latest Publications

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.